These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 2067963

  • 1. Factors related to amphotericin-B-induced rigors (shivering).
    Carney-Gersten P, Giuffre M, Levy D.
    Oncol Nurs Forum; 1991; 18(4):745-50. PubMed ID: 2067963
    [Abstract] [Full Text] [Related]

  • 2. Amphotericin B-induced shivering in patients with cancer: a nursing approach.
    Rutledge DN, Holtzclaw BJ.
    Heart Lung; 1988 Jul; 17(4):432-40. PubMed ID: 3292467
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of nefopam for the prevention and treatment of amphotericin B-induced shivering.
    Rosa G, Dell'Utri D, Conti G, Pelaia P, Cogliati A, Orsi P, Gasparetto A.
    Arch Intern Med; 1997 Jul 28; 157(14):1589-92. PubMed ID: 9236561
    [Abstract] [Full Text] [Related]

  • 4. Effects of extremity wraps to control drug-induced shivering: a pilot study.
    Holtzclaw BJ.
    Nurs Res; 1990 Jul 28; 39(5):280-3. PubMed ID: 2399132
    [Abstract] [Full Text] [Related]

  • 5. Control of febrile shivering during amphotericin B therapy.
    Holtzclaw BJ.
    Oncol Nurs Forum; 1990 Jul 28; 17(4):521-4. PubMed ID: 2399165
    [Abstract] [Full Text] [Related]

  • 6. Factors related to amphotericin-B-induced rigors.
    Bohan CB.
    Oncol Nurs Forum; 1992 Apr 28; 19(3):395. PubMed ID: 1594462
    [No Abstract] [Full Text] [Related]

  • 7. Amphotericin B revisited: reassessment of toxicity.
    Clements JS, Peacock JE.
    Am J Med; 1990 May 28; 88(5N):22N-27N. PubMed ID: 2368770
    [Abstract] [Full Text] [Related]

  • 8. [Liposomal amphotericin B in the treatment of severe fungal infections. Results of a clinical cohort trial].
    Rieger CT, Dittmer M, Ostermann H.
    Dtsch Med Wochenschr; 2007 Oct 28; 132(40):2062-6. PubMed ID: 17899499
    [Abstract] [Full Text] [Related]

  • 9. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial).
    Cornely OA, Maertens J, Bresnik M, Ebrahimi R, Ullmann AJ, Bouza E, Heussel CP, Lortholary O, Rieger C, Boehme A, Aoun M, Horst HA, Thiebaut A, Ruhnke M, Reichert D, Vianelli N, Krause SW, Olavarria E, Herbrecht R, AmBiLoad Trial Study Group.
    Clin Infect Dis; 2007 May 15; 44(10):1289-97. PubMed ID: 17443465
    [Abstract] [Full Text] [Related]

  • 10. Amphotericin B colloidal dispersion (Amphocil) vs fluconazole for the prevention of fungal infections in neutropenic patients: data of a prematurely stopped clinical trial.
    Timmers GJ, Zweegman S, Simoons-Smit AM, van Loenen AC, Touw D, Huijgens PC.
    Bone Marrow Transplant; 2000 Apr 15; 25(8):879-84. PubMed ID: 10808210
    [Abstract] [Full Text] [Related]

  • 11. Implementation of clinical practice policy on the continuous intravenous administration of amphotericin B deoxycholate.
    Maharom P, Thamlikitkul V.
    J Med Assoc Thai; 2006 Nov 15; 89 Suppl 5():S118-24. PubMed ID: 17718252
    [Abstract] [Full Text] [Related]

  • 12. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
    Cobo Reinoso P, Aguado García JM, Lumbreras Bermejo C, Pérez Vela JL, Caballero Cubedo R, Sanz Sanz F, Noriega Rodríguez AR.
    Rev Clin Esp; 1997 Dec 15; 197(12):799-803. PubMed ID: 9477669
    [Abstract] [Full Text] [Related]

  • 13. Prospective surveillance of intravenous amphotericin B use patterns.
    Grasela TH, Goodwin SD, Walawander MK, Cramer RL, Fuhs DW, Moriarty VP.
    Pharmacotherapy; 1990 Dec 15; 10(5):341-8. PubMed ID: 2235670
    [Abstract] [Full Text] [Related]

  • 14. Rapid infusion amphotericin B: effective and well-tolerated therapy for neutropenic fever.
    Spitzer TR, Creger RJ, Fox RM, Lazarus HM.
    Pharmatherapeutica; 1989 Dec 15; 5(5):305-11. PubMed ID: 2748690
    [Abstract] [Full Text] [Related]

  • 15. Treatment of invasive fungal sinusitis with liposomal amphotericin B: a report of four cases.
    Sungkanuparph S, Sathapatayavongs B, Kunachak S, Luxameechanporn T, Cheewaruangroj W.
    J Med Assoc Thai; 2001 Apr 15; 84(4):593-601. PubMed ID: 11460976
    [Abstract] [Full Text] [Related]

  • 16. Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation.
    Borro JM, Solé A, de la Torre M, Pastor A, Fernandez R, Saura A, Delgado M, Monte E, Gonzalez D.
    Transplant Proc; 2008 Nov 15; 40(9):3090-3. PubMed ID: 19010204
    [Abstract] [Full Text] [Related]

  • 17. [Intravenous amphotericin B as prevention of deep mycoses in allogeneic bone marrow transplantation].
    Carreras E, Batlle M, Redondo M, Esteve J, Ros S, Rovira M, Sierra J, Urbano-Ispizua A, Marín P, Merino A.
    Med Clin (Barc); 1994 Dec 10; 103(20):761-5. PubMed ID: 7861833
    [Abstract] [Full Text] [Related]

  • 18. Shivering following cardiac surgery: predictive factors, consequences, and characteristics.
    Spaniol SE, Bond EF, Brengelmann GL, Savage M, Pozos RS.
    Am J Crit Care; 1994 Sep 10; 3(5):356-67. PubMed ID: 8000459
    [Abstract] [Full Text] [Related]

  • 19. Treatment of systemic fungal infections with liposomal amphotericin B.
    Lopez-Berestein G, Bodey GP, Fainstein V, Keating M, Frankel LS, Zeluff B, Gentry L, Mehta K.
    Arch Intern Med; 1989 Nov 10; 149(11):2533-6. PubMed ID: 2818111
    [Abstract] [Full Text] [Related]

  • 20. Retrospective study of the renal effects of amphotericin B lipid complex when used at higher-than-recommended dosages and longer durations compared with lower dosages and shorter durations in patients with systemic fungal infections.
    Hooshmand-Rad R, Reed MD, Chu A, Gotz V, Morris JA, Weinberg J, Dominguez EA.
    Clin Ther; 2004 Oct 10; 26(10):1652-62. PubMed ID: 15598482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.